| Date Filed | Type | Description |
| 05/31/2023 |
4
| Kantoff Philip W. (Director) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.87, valued at
$21.8k
|
|
| 05/31/2023 |
4
| West Linda (Director) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.87, valued at
$21.8k
|
|
| 05/31/2023 |
4
| Stacey Jennifer Evans (Director) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $0.87, valued at
$21.8k
|
|
| 05/31/2023 |
4
| BERMAN RICHARD J (Director) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.87, valued at
$43.5k
|
|
| 02/21/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 5,823 shares
@ $0.8415, valued at
$4.9k
|
|
| 02/14/2023 |
4
| Levit Alex C. (Chief Legal Officer, Corp. Sec) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 151,505 options to buy
@ $0.8407, valued at
$127.4k
|
|
| 02/14/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 287,544 options to buy
@ $0.8407, valued at
$241.7k
|
|
| 02/14/2023 |
4
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 158,001 options to buy
@ $0.8407, valued at
$132.8k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 7,027 shares
@ $0.6974, valued at
$4.9k
|
|
| 01/23/2023 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 6,839 shares
@ $0.7166, valued at
$4.9k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 20,000 shares
@ $0.7398, valued at
$14.8k
|
|
| 12/12/2022 |
4
| Levit Alex C. (Chief Legal Officer, Corp. Sec) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 6,000 shares
@ $0.8491, valued at
$5.1k
|
|
| 08/22/2022 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 13,000 shares
@ $1.8511, valued at
$24.1k
|
|
| 08/17/2022 |
4
| Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 15,000 shares
@ $1.8, valued at
$27k
|
|
| 08/17/2022 |
4
| Sahmoud Tarek (Chief Medical Officer) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 10,000 shares
@ $1.95, valued at
$19.5k
|
|
| 08/12/2022 |
4
| Sahmoud Tarek (Chief Medical Officer) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.96, valued at
$49k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Levit Alex C. (Chief Legal Officer, Corp. Sec) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 107,870 options to buy
@ $1.79, valued at
$193.1k
|
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 254,300 options to buy
@ $1.79, valued at
$455.2k
|
|
| 02/17/2022 |
4
| Dick Evan G. (Former Section 16 officer) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 29,223 options to buy
@ $2.05, valued at
$59.9k
|
|
| 02/17/2022 |
4
| Rencher William F. (Former Section 16 officer) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Granted 8,000 options to buy
@ $2.05, valued at
$16.4k
|
|
| 12/20/2021 |
4
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Bought 13,000 shares
@ $3.2192, valued at
$41.8k
|
|
| 12/17/2021 |
4/A
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Converted 210,715 shares
@ $0
Converted 586,475 shares
@ $0
Bought 10,000 shares
@ $5, valued at
$50k
Exercised (out-of-the-money) 52,680 warrants
@ $7.14, valued at
$376.1k
Converted 210,715 preferred shares
@ $0
Converted 586,475 options to buy
@ $0 |
|
| 12/17/2021 |
4/A
| Dick Evan G. (SVP of R&D) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Converted 26,587 shares
@ $0
Converted 26,587 options to buy
@ $0 |
|
| 12/17/2021 |
3/A
| Dick Evan G. (SVP of R&D) has filed a Form 3/A on Context Therapeutics Inc. |
| 12/17/2021 |
3/A
| Rencher William F. (Head of CMC and Regulatory) has filed a Form 3/A on Context Therapeutics Inc. |
|